Press Releases

Dr. Greenberg presented new preclinical data from Vivreon Biosciences' Alzheimer's disease therapeutic program at the 18th International Conference on Alzheimer's Drug Discovery in Jersey City, NJ.

 

News

Vivreon presented our exciting preclinical data for our VV2003 ulcerative colitis program at Digestive Diseases Week 2017 in Chicago, IL.

Vivreon Biosciences Presents Data at International Conference on Alzheimer's Drug Discovery

Vivreon Biosciences Achieves Milestones in SBIR Grant from the National Institute on Aging

 

Vivreon Biosciences Announces Hiring of Chief Scientific Officer

 

Vivreon Biosciences Awarded Grant from Alzheimer's Drug Discovery Foundation

Vivreon Biosciences

 

Copyright 2017. Vivreon Biosciences. All rights reserved. 

Vivreon Biosciences

Oral Immune Therapeutics